XML Financial »

Iovance Biotherapeutics shares owned by XML Financial

Quarter-by-quarter ownership of Iovance Biotherapeutics (IOVA) shares owned by XML Financial from 13F filings

Historical chart of XML Financial investment in Iovance Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Iovance Biotherapeutics held by XML Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Iovance Biotherapeutics by XML Financial

Quarter filed Position value Share count Share price at filing
2024-03-31 $193k 13k 14.82

More positions owned by XML Financial

Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Schwab Strategic Tr Us Lcap Va Etf (SCHV)
Microsoft Corporation (MSFT)
Ishares Tr Rus 1000 Grw Etf (IWF)
Ishares Tr Core Div Grwth (DGRO)
Ishares Tr Rus 1000 Etf (IWB)
Ishares Tr Rus Mid Cap Etf (IWR)
Apple (AAPL)
Vanguard World Inf Tech Etf (VGT)
PIMCO Corporate Opportunity Fund (PTY)
Ishares Tr Core S&p Scp Etf (IJR)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Spdr Ser Tr Bbg Conv Sec Etf (CWB)
Qualcomm (QCOM)

View all positions for XML Financial

Top funds holding Iovance Biotherapeutics

Vanguard Group
MHR Fund Management
BlackRock
Perceptive Advisors
venBio Select Advisor
Geode Capital Management
T. Rowe Price Associates
Artisan Partners Limited Partnership
Susquehanna International
Jpmorgan Chase & Co
Goldman Sachs Group
Soleus Capital Management
Voloridge Investment Management
Pictet Asset Management Holding SA
Summit Partners Public Asset Management

View all funds holding Iovance Biotherapeutics